- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 69-83 of
316 results
No. 29
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 29 (N.D.W.Va. May. 19, 2022)
|
|
Cite Document
No. 28
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 28 (N.D.W.Va. May. 19, 2022)
|
|
Cite Document
No. 27
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 27 (N.D.W.Va. May. 16, 2022)
|
|
Cite Document
No. 26
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 26 (N.D.W.Va. May. 11, 2022)
|
|
Cite Document
No. 25
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25 (N.D.W.Va. May. 11, 2022)
|
|
Cite Document
No. 22
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 20
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 20 (N.D.W.Va. Apr. 8, 2022)
|
|
Cite Document
No. 13
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 13 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 5
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 5 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 3
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 3 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 6
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 6 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 1 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 4
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 4 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
8 Other other: Patent Owner’s Sur Reply to Petitioner’s Reply to Patent Owners Pr...
Document
IPR2023-00723, No. 8 Other other - Patent Owner’s Sur Reply to Petitioner’s Reply to Patent Owners Preliminary Response (P.T.A.B. Aug. 17, 2023)
|
|
Cite Document
